REFERENCES
1. Odaman AI, Bayram C, Koc B, Ersoy G, Pasli UE, Aki H, et al. Burkitt Leukemia With Precursor B-Cell Immunophenotype and Dual Translocation of t(14;18) and t(8;14) in a Child: Case Report and Review of the Literature. J Pediatr Hematol Oncol. 2020 2020-01-01;42(1):e61-3.
2. Jacobson C, LaCasce A. How I treat Burkitt lymphoma in adults. BLOOD. 2014 2014-11-06;124(19):2913-20.
3. Herbrueggen H, Mueller S, Rohde J, Arias PL, Moericke A, Attarbaschi A, et al. Treatment and outcome of IG-MYC(+) neoplasms with precursor B-cell phenotype in childhood and adolescence. LEUKEMIA. 2020 2020-03-01;34(3):942-6.
4. Polyatskin IL, Artemyeva AS, Krivolapov YA. [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors]. Arkh Patol. 2019 2019-01-20;81(3):59-65.
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 1976-08-01;33(4):451-8.
6. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). LEUKEMIA. 1995 1995-10-01;9(10):1783-6.
7. Lilljebjorn H, Henningsson R, Hyrenius-Wittsten A, Olsson L, Orsmark-Pietras C, von Palffy S, et al. Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. NAT COMMUN. 2016 2016-06-06;7:11790.
8. Blum KA, Lozanski G, Byrd JC. Adult Burkitt leukemia and lymphoma. BLOOD. 2004 2004-11-15;104(10):3009-20.
9. Shen S, Cai J, Chen J, Xue H, Pan C, Gao Y, et al. Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China. HEMATOL ONCOL. 2018 2018-10-01;36(4):679-88.
10. de Barrios O, Meler A, Parra M. MYC’s Fine Line Between B Cell Development and Malignancy. CELLS-BASEL. 2020 2020-02-24;9(2).
11. Habib T, Park H, Tsang M, de Alboran IM, Nicks A, Wilson L, et al. Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J CELL BIOL. 2007 2007-11-19;179(4):717-31.
12. Davis M, Malcolm S, Rabbitts TH. Chromosome translocation can occur on either side of the c-myc oncogene in Burkitt lymphoma cells. NATURE. 1984 1984-03-15;308(5956):286-8.
13. Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T. Spatial proximity of translocation-prone gene loci in human lymphomas. NAT GENET. 2003 2003-07-01;34(3):287-91.
14. Navid F, Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM, et al. Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. LEUKEMIA. 1999 1999-01-01;13(1):135-41.
15. Sakaguchi K, Imamura T, Ishimaru S, Imai C, Shimonodan H, Fujita N, et al. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan. PEDIATR BLOOD CANCER. 2020 2020-07-01;67(7):e28341.
16. Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015 2015-10-15;373(16):1541-52.
17. Colin VM, Auperin A, Pillon M, Burke A, Anderson J, Barkausk D, et al. Results of the Randomized Intergroup Trial Inter-B-NHL RITUX 2010 for Children/Adolescents with High-Risk B-Cell Non Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL). Pediatric blood & cancer. 2016;63(Suppl.3):S31.
18. Wagener R, Lopez C, Kleinheinz K, Bausinger J, Aukema SM, Nagel I, et al. IG-MYC (+) neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. BLOOD. 2018 2018-11-22;132(21):2280-5.
19. Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. ONCOGENE. 2001 2001-09-10;20(40):5580-94.